Navigation Links
Chloroform provides clue to 150 year old medical puzzle
Date:3/31/2008

One of the earliest general anaesthetics to be used by the medical profession, chloroform, has shed light on a mystery thats puzzled doctors for more than 150 years how such anaesthetics actually work.

A discovery described as true serendipity made by Leeds University PhD student Dr Yahya Bahnasi, has provided a clue that may unravel the enigma of general anaesthesia and offer the opportunity to design new generations of anaesthetics without harmful side effects.

We take general anaesthesia for granted nowadays, but its still true to say that we dont know exactly how it works on a molecular level, says Dr Bahnasi, a qualified medical doctor on an Egyptian Ministry of Higher Education Scholarship at the Universitys Faculty of Biological Sciences.

However, I was examining the relationship between lipids and atherosclerosis [the furring up of arteries] and it just so happened that the lipids I was using were supplied already dissolved in chloroform. I noticed that the chloroform inhibited, or blocked, the calcium ion channel TRPC5 it was quite a striking effect.

Ion channels are pathways that allow electrically charged atoms to pass across cell membranes to carry out various functions such as pain transmission and the timing of the heart beat. TRPC5 calcium ion channels are found in many tissues around the body but are predominant in the brain.

We know that this ion channel plays a signalling role in the central nervous system, which regulates the conscious and unconscious states, so I was left wondering whether inhibiting this calcium ion channel was one mechanism by which anaesthesia works, says Dr Bahnasi.

Dr Bahnasi then carried out further experiments with several other modern anaesthetic compounds, both intravenous and inhaled, and found that the blocking effect on the TRPC5 ion channel was the same.

He says that the discovery opens up the opportunity to design and develop new generations of anaesthetics which directly target TRPC5, but with minimised side effects.

Of course there are multi-molecular events that work together in anaesthesia, and inhibiting the TRPC5 ion channel may just be one of them. But its a great start in piecing together the underlying mechanisms and providing a novel molecular target for new drug design, he says. And its particularly fitting that this evidence was revealed by chloroform, the grandfather of modern anaesthetics.


'/>"/>

Contact: Jo Kelly
jokelly@campuspr.co.uk
44-113-258-9880
University of Leeds
Source:Eurekalert

Related biology news :

1. Bioinformatics technology developed at Argonne provides new insight into microbial activities
2. Research with squirrels provides clues on hormones role in human learning
3. Researcher provides tool to enable determination of age of anchovies with greater precision
4. Scripps expedition provides new baseline for coral reef conservation
5. Mesothelin engineered on virus-like particles provides treatment clues for pancreatic cancer
6. Antarctic expedition provides new insights into the role of the Southern Ocean for global climate
7. HIV isolate from Kenya provides clues for vaccine design
8. Book on little-known species and conservation provides guidance to managers and others
9. Shell Provides Consumers Gasoline Industrys First Pay By Touch Technology at the Pump
10. Study involving more than 100 scientists provides new insights on green algae
11. Canada provides $1.4M for removal of hazardous trees from provincial recreation sites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: